Cargando…
Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated w...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416813/ https://www.ncbi.nlm.nih.gov/pubmed/37577110 http://dx.doi.org/10.1093/ofid/ofad400 |
_version_ | 1785087866376814592 |
---|---|
author | Hanna, John J Geresu, Liyu B Diaz, Marlon I Ho, Milan Casazza, Julia A Pickering, Madison A Lanier, Heather D Radunsky, Alexander P Cooper, Lauren N Saleh, Sameh N Bedimo, Roger J Most, Zachary M Perl, Trish M Lehmann, Christoph U Turer, Robert W Chow, Jeremy Y Medford, Richard J |
author_facet | Hanna, John J Geresu, Liyu B Diaz, Marlon I Ho, Milan Casazza, Julia A Pickering, Madison A Lanier, Heather D Radunsky, Alexander P Cooper, Lauren N Saleh, Sameh N Bedimo, Roger J Most, Zachary M Perl, Trish M Lehmann, Christoph U Turer, Robert W Chow, Jeremy Y Medford, Richard J |
author_sort | Hanna, John J |
collection | PubMed |
description | BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated with SARS-CoV-2 positivity among PWH and risk factors for severe outcomes, including hospitalization, intensive care unit stays, and death. A subset analysis was conducted to examine HIV-specific variables. Multiple variable logistic regression was used to adjust for covariates. RESULTS: Of 43 173 PWH included in this study, 6472 had a positive SARS-CoV-2 result based on a polymerase chain reaction test or antigen test. For PWH with SARS-CoV-2 positivity, higher odds were found for those who were younger (18–49 years), Hispanic White, African American, from the US South, uninsured, and a noncurrent smoker and had a higher body mass index and higher Charlson Comorbidity Index. For PWH with severe outcomes, higher odds were identified for those who were SARS-CoV-2 positive, older, from the US South, receiving Medicaid/Medicare or uninsured, a current smoker, and underweight and had a higher Charlson Comorbidity Index. In a subset analysis including PWH with HIV care variables (n = 5098), those with unsuppressed HIV viral load, a low CD4 count, and no antiretroviral therapy had higher odds of severe outcomes. CONCLUSIONS: This large US study found significant ethnic, racial, and geographic differences in SARS-CoV-2 infection among PWH. Chronic comorbidities, older age, lower body mass index, and smoking were associated with severe outcomes among PWH during the COVID-19 pandemic. SARS-CoV-2 infection was associated with severe outcomes, but once we adjusted for HIV care variables, SARS-CoV-2 was no longer significant; however, low CD4 count, high viral load, and lack of antiretroviral therapy had higher odds of severe outcomes. |
format | Online Article Text |
id | pubmed-10416813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104168132023-08-12 Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study Hanna, John J Geresu, Liyu B Diaz, Marlon I Ho, Milan Casazza, Julia A Pickering, Madison A Lanier, Heather D Radunsky, Alexander P Cooper, Lauren N Saleh, Sameh N Bedimo, Roger J Most, Zachary M Perl, Trish M Lehmann, Christoph U Turer, Robert W Chow, Jeremy Y Medford, Richard J Open Forum Infect Dis Major Article BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated with SARS-CoV-2 positivity among PWH and risk factors for severe outcomes, including hospitalization, intensive care unit stays, and death. A subset analysis was conducted to examine HIV-specific variables. Multiple variable logistic regression was used to adjust for covariates. RESULTS: Of 43 173 PWH included in this study, 6472 had a positive SARS-CoV-2 result based on a polymerase chain reaction test or antigen test. For PWH with SARS-CoV-2 positivity, higher odds were found for those who were younger (18–49 years), Hispanic White, African American, from the US South, uninsured, and a noncurrent smoker and had a higher body mass index and higher Charlson Comorbidity Index. For PWH with severe outcomes, higher odds were identified for those who were SARS-CoV-2 positive, older, from the US South, receiving Medicaid/Medicare or uninsured, a current smoker, and underweight and had a higher Charlson Comorbidity Index. In a subset analysis including PWH with HIV care variables (n = 5098), those with unsuppressed HIV viral load, a low CD4 count, and no antiretroviral therapy had higher odds of severe outcomes. CONCLUSIONS: This large US study found significant ethnic, racial, and geographic differences in SARS-CoV-2 infection among PWH. Chronic comorbidities, older age, lower body mass index, and smoking were associated with severe outcomes among PWH during the COVID-19 pandemic. SARS-CoV-2 infection was associated with severe outcomes, but once we adjusted for HIV care variables, SARS-CoV-2 was no longer significant; however, low CD4 count, high viral load, and lack of antiretroviral therapy had higher odds of severe outcomes. Oxford University Press 2023-07-24 /pmc/articles/PMC10416813/ /pubmed/37577110 http://dx.doi.org/10.1093/ofid/ofad400 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Hanna, John J Geresu, Liyu B Diaz, Marlon I Ho, Milan Casazza, Julia A Pickering, Madison A Lanier, Heather D Radunsky, Alexander P Cooper, Lauren N Saleh, Sameh N Bedimo, Roger J Most, Zachary M Perl, Trish M Lehmann, Christoph U Turer, Robert W Chow, Jeremy Y Medford, Richard J Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title | Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title_full | Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title_fullStr | Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title_full_unstemmed | Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title_short | Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study |
title_sort | risk factors for sars-cov-2 infection and severe outcomes among people with human immunodeficiency virus: cohort study |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416813/ https://www.ncbi.nlm.nih.gov/pubmed/37577110 http://dx.doi.org/10.1093/ofid/ofad400 |
work_keys_str_mv | AT hannajohnj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT geresuliyub riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT diazmarloni riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT homilan riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT casazzajuliaa riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT pickeringmadisona riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT lanierheatherd riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT radunskyalexanderp riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT cooperlaurenn riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT salehsamehn riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT bedimorogerj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT mostzacharym riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT perltrishm riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT lehmannchristophu riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT turerrobertw riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT chowjeremyy riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy AT medfordrichardj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy |